Patient Considerations in the Use of Transdermal Iontophoretic Fentanyl for Acute Postoperative Pain

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2016 May 18

PMID 27186073

Citations 3

Authors

Craig T Hartrick

Cecile R Pestano

Li Ding

Hassan Danesi

James B Jones

Affiliations

Soon will be listed here.

Abstract

Opioids are commonly used in the management of moderate-to-severe postoperative pain. Patient-controlled analgesic techniques are recognized as preferred administration methods. Previously, research has focused on intravenously administered opioids via a programmable pump. More recently, an iontophoretic transdermal system (ITS), which is patient controlled, has been developed. The focus of this review is on pain management using the fentanyl ITS during the 24-72-hour time period immediately following surgery. Fentanyl ITS offers a needle-free alternative to traditional intravenous (IV) patient-controlled analgesia (PCA) system that is as effective and safe as IV PCA. This system is easy to use for both patients and nurses. The use of fentanyl ITS is generally associated with a better ease-of-care profile, including a greater ease of mobility, from a patients' perspective when compared with morphine IV PCA.

Citing Articles

Postoperative pain management in the postanesthesia care unit: an update.

Luo J, Min S J Pain Res. 2017; 10:2687-2698.

PMID: 29180895 PMC: 5695271. DOI: 10.2147/JPR.S142889.

Fentanyl Formulations in the Management of Pain: An Update.

Schug S, Ting S Drugs. 2017; 77(7):747-763.

PMID: 28337672 DOI: 10.1007/s40265-017-0727-z.

High Body Mass Index and Use of Fentanyl Iontophoretic Transdermal System in Postoperative Pain Management: Results of a Pooled Analysis of Six Phase 3/3B Trials.

Viscusi E, Ding L, Phipps J, Itri L, Schauer P Pain Ther. 2016; 6(1):29-43.

PMID: 28004310 PMC: 5447541. DOI: 10.1007/s40122-016-0064-z.

References

Kessler E, Shah M, Gruschkus S, Raju A . Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013; 33(4):383-91. DOI: 10.1002/phar.1223. View

Lopez-Munoz F, Alamo C . The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Res Bull. 2009; 79(2):130-41. DOI: 10.1016/j.brainresbull.2009.01.005. View

Gupta S, Bernstein K, Noorduin H, Van Peer A, Sathyan G, Haak R . Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol. 1998; 38(10):951-8. DOI: 10.1002/j.1552-4604.1998.tb04392.x. View

Stanley T . The history and development of the fentanyl series. J Pain Symptom Manage. 1992; 7(3 Suppl):S3-7. DOI: 10.1016/0885-3924(92)90047-l. View

. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012; 116(2):248-73. DOI: 10.1097/ALN.0b013e31823c1030. View

Sinatra R, Viscusi E, Ding L, Danesi H, Jones J, Grond S . Meta-analysis of the efficacy of the fentanyl iontophoretic transdermal system versus intravenous patient-controlled analgesia in postoperative pain management. Expert Opin Pharmacother. 2015; 16(11):1607-13. DOI: 10.1517/14656566.2015.1054279. View

Joshi N, Lemke J, Danesi H . Design and functionality of a smart fentanyl iontophoretic transdermal system for the treatment of moderate-to-severe postoperative pain. Pain Manag. 2016; 6(2):137-45. DOI: 10.2217/pmt.15.70. View

Minkowitz H, Rathmell J, Vallow S, Gargiulo K, Damaraju C, Hewitt D . Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med. 2007; 8(8):657-68. DOI: 10.1111/j.1526-4637.2006.00257.x. View

Viscusi E, Reynolds L, Chung F, Atkinson L, Khanna S . Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA. 2004; 291(11):1333-41. DOI: 10.1001/jama.291.11.1333. View

10.

Camu F, Van Aken H, Bovill J . Postoperative analgesic effects of three demand-dose sizes of fentanyl administered by patient-controlled analgesia. Anesth Analg. 1998; 87(4):890-5. DOI: 10.1097/00000539-199810000-00027. View

11.

Delaney C, Zutshi M, Senagore A, Remzi F, Hammel J, Fazio V . Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum. 2003; 46(7):851-9. DOI: 10.1007/s10350-004-6672-4. View

12.

Markey D, Brown R . An interdisciplinary approach to addressing patient activity and mobility in the medical-surgical patient. J Nurs Care Qual. 2002; 16(4):1-12. DOI: 10.1097/00001786-200207000-00002. View

13.

Viscusi E, Grond S, Ding L, Danesi H, Jones J, Sinatra R . A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain. Pain Manag. 2015; 6(1):19-24. DOI: 10.2217/pmt.15.49. View

14.

Grond S, Hall J, Spacek A, Hoppenbrouwers M, Richarz U, Bonnet F . Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management. Br J Anaesth. 2007; 98(6):806-15. DOI: 10.1093/bja/aem102. View

15.

McNicol E, Ferguson M, Hudcova J . Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database Syst Rev. 2015; (6):CD003348. PMC: 7387354. DOI: 10.1002/14651858.CD003348.pub3. View

16.

Hartrick C, Bourne M, Gargiulo K, Damaraju C, Vallow S, Hewitt D . Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery: a comparative study with morphine intravenous patient-controlled analgesia. Reg Anesth Pain Med. 2006; 31(6):546-54. DOI: 10.1016/j.rapm.2006.08.011. View

17.

Viscusi E, Reynolds L, Tait S, Melson T, Atkinson L . An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth Analg. 2005; 102(1):188-94. DOI: 10.1213/01.ane.0000183649.58483.77. View

18.

Strassels S, McNicol E, Suleman R . Postoperative pain management: a practical review, part 1. Am J Health Syst Pharm. 2005; 62(18):1904-16. DOI: 10.2146/ajhp040490.p1. View

19.

Chelly J, Grass J, Houseman T, Minkowitz H, Pue A . The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth Analg. 2004; 98(2):427-433. DOI: 10.1213/01.ANE.0000093314.13848.7E. View

20.

Rothman M, Vallow S, Damaraju C, Hewitt D . Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials. Curr Med Res Opin. 2009; 25(6):1433-43. DOI: 10.1185/03007990902862032. View